Mallinckrodt Loses $9.5M Award But Wins Delay In Airgas Drug

By Adam Lidgett · November 3, 2026, 8:32 PM EST

A Delaware federal judge on Tuesday threw out Mallinckrodt Pharmaceuticals' $9.5 million jury award it won in an infringement case and instead blocked a competitor's inhaled nitric oxide treatment patent until...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Mallinckrodt Pharmaceuticals Ireland Limited et al v. Airgas Therapeutics LLC et al

Case Number

1:22-cv-01648

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

December 30, 2022